The resting state amplitude of low frequency fluctuations (ALFF) in functional magnetic resonance imaging has been shown to be reliable in healthy subjects, and to correlate with antipsychotic treatment response in antipsychotic-naïve schizophrenia patients. We found moderate to high test-retest stability of ALFF in chronically treated schizophrenia patients assessed twice over a median interval of 2.5 months.
Introduction
Resting state functional magnetic resonance imaging (fMRI) studies of schizophrenia have typically focused on functional connectivity, i.e., the degree of temporal correlation of the BOLD signal among anatomically distributed brain regions. Different connectivity patterns within and between several functionally distinct networks have been reported in healthy and schizophrenia groups (Liang et al., 2006; Liu et al., 2006; Jafri et al., 2008; Lui et al., 2009a) .
The amplitude of low frequency fluctuations (ALFF) can also be measured from resting fMRI data. These low frequency fluctuations, slower than cardiac or respiratory fluctuations, are considered to be related to spontaneous neural activity within a region, and contribute strongly to the correlations seen in BOLD signal time courses across regions (Cordes et al., 2001; Yang et al., 2007; Lui et al., 2009b) . ALFF has recently been shown to be reduced in schizophrenia in cross-sectional studies, albeit with some regional inconsistencies (Hoptman et al., 2010; Huang et al., 2010) . A promising longitudinal study, however, reported an increase (normalization) of frontal and parietal ALFF in antipsychotic-naïve schizophrenia patients after 6 weeks of antipsychotic drug treatment (Lui et al., 2010) . Hence, ALFF may provide a relatively easy and safe method to track antipsychotic response in clinical populations and may shed light on the mechanism of action of these agents. However, the test-retest reliability of ALFF has only been examined in healthy volunteers to date (Zuo et al., 2010) , and it is unclear whether ALFF is reliable and stable over the short-term illness course in chronically treated persons with schizophrenia. A related measure, fractional ALFF or fALFF, measures the amount of power in the lower frequency spectrum relative to the total power in the detectable range; however, it is slightly less reliable than ALFF in healthy controls (Zuo et al., 2010) . Thus, in the present study we examined the stability of ALFF, with a median test-retest interval of 2.5 months in subjects with chronic schizophrenia.
Materials and methods

Subjects
The study was approved by the UNM Institutional Review Board (IRB). Data represent a convenience sample, aggregated across studies that collected the same resting state scan on the same scanner. Twenty-one outpatients with DSM-IV-TR schizophrenia (diagnosed based on the Structured Clinical Interview for DSM-IV (First et al., 2002) provided informed consent and participated in the multiple studies. Subjects were outpatients ranging in age from 23 to 62 years (mean 42 years). Positive, negative, and general symptom severity as measured by the Positive and Negative Syndrome Scale (PANSS; (Kay et al., 1987) ) were assessed for each subject within 1 week of each scan. All were treated with antipsychotic medication with clinically equivalent olanzapine dosages ranging from 2.5 to 70 mg/day (Gardner et al., 2010 
